Summary:
«Beacon Biosignals, a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain, has announced an oversubscribed $27M Series A financing led by General Catalyst and with participation from Casdin Capital. This capital brings Beacon Biosignals’ total funding to date to $30M..»
Article written by Fred Pennic.
11|08|2021
Source:
HITConsultant
https://hitconsultant.net/2021/11/08/beacon-biosignals-eeg-neurobiomarker-funding/